300705 Stock Overview
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 300705 from our risk checks.
Hunan Jiudian Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥37.36 |
| 52 Week High | CN¥39.00 |
| 52 Week Low | CN¥18.80 |
| Beta | 0.48 |
| 1 Month Change | 3.95% |
| 3 Month Change | 31.73% |
| 1 Year Change | 40.72% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 29.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300705 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.7% | 5.6% | 3.1% |
| 1Y | 40.7% | -11.0% | -13.1% |
Return vs Industry: 300705 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 300705 exceeded the CN Market which returned -13.1% over the past year.
Price Volatility
| 300705 volatility | |
|---|---|
| 300705 Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 7.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300705 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300705's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,636 | Xia Hui Zheng | www.hnjiudian.com |
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields.
Hunan Jiudian Pharmaceutical Co., Ltd. Fundamentals Summary
| 300705 fundamental statistics | |
|---|---|
| Market cap | CN¥12.89b |
| Earnings (TTM) | CN¥417.04m |
| Revenue (TTM) | CN¥2.78b |
30.9x
P/E Ratio4.6x
P/S RatioIs 300705 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300705 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.78b |
| Cost of Revenue | CN¥650.94m |
| Gross Profit | CN¥2.13b |
| Other Expenses | CN¥1.71b |
| Earnings | CN¥417.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.21 |
| Gross Margin | 76.60% |
| Net Profit Margin | 14.99% |
| Debt/Equity Ratio | 33.2% |
How did 300705 perform over the long term?
See historical performance and comparison